CLINICAL_TRIALS
trial_result
· 2021-02-01
Clinical Trial Update: The Efficacy of Cobitolimod in Patients With Moderate to Severe Active Ulcerative Colitis [Phase 2]
Summary
Phase 2 trial update on cobitolimod for moderate to severe active ulcerative colitis showing completed results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: InDex Pharmaceuticals | Conditions: Ulcerative Colitis | Phase 2 | Status: COMPLETED | Results posted: 2021-02-01